China Pharma Holdings (CPHI) Current Leases (2019 - 2026)
China Pharma Holdings (CPHI) reported Current Leases of $71386.0 for Q1 2026, up 260.97% on a YoY basis from $19776.0 in Q1 2025, and little changed quarter-over-quarter from $71628.0 in Q4 2025.
China Pharma Holdings (CPHI) Current Leases (2019 - 2026) Analysis & Trends
China Pharma Holdings has reported Current Leases for 8 years, with the latest figure at $71386.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 260.97% year-over-year to $71386.0; the trailing twelve-month figure through Mar 2026 stood at $71386.0 (up 260.97% YoY), and the FY2025 full-year result was $71628.0, up 82.15% from the prior year.
- Current Leases for Q1 2026 stood at $71386.0, roughly flat from $71628.0 in the prior quarter.
- The five-year high for Current Leases was $86672.0 in Q1 2022, with the low at $19776.0 in Q1 2025.
- Historically, Current Leases has averaged $63001.6 across 5 years, with a median of $71507.0 in 2025.
- Annual changes were most pronounced in 2023 — Current Leases slumped 76.21% — and 2024, when it jumped 279.71%.
- China Pharma Holdings' Current Leases stood at $40445.0 in 2022, then jumped by 92.18% to $77727.0 in 2023, then plunged by 49.41% to $39323.0 in 2024, then jumped by 82.15% to $71628.0 in 2025, then dropped by 0.34% to $71386.0 in 2026.
- The last three Current Leases figures came in at $71386.0 (Q1 2026), $71628.0 (Q4 2025), and $70326.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 23.81 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 7.58 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 5.58 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | 71,386.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,386.00 |
| Dec 31, 2025 | 71,628.00 |
| Sep 30, 2025 | 70,326.00 |
| Mar 31, 2025 | 19,776.00 |
| Dec 31, 2024 | 39,323.00 |
| Sep 30, 2024 | 60,241.00 |
| Jun 30, 2024 | 78,628.00 |
| Mar 31, 2024 | 78,284.00 |
| Dec 31, 2023 | 77,727.00 |
| Sep 30, 2023 | 76,000.00 |
| Jun 30, 2023 | 74,850.00 |
| Mar 31, 2023 | 20,617.00 |
| Dec 31, 2022 | 40,445.00 |
| Sep 30, 2022 | 59,163.00 |
| Jun 30, 2022 | 82,959.00 |
| Mar 31, 2022 | 86,672.00 |
| Dec 31, 2021 | 85,282.00 |
| Sep 30, 2021 | 82,851.00 |
| Jun 30, 2021 | 83,707.00 |
| Mar 31, 2021 | 26,743.00 |